SCHEMBL8307816

SCHEMBL8307816

Nc1cccc(-c2cccc(Cl)c2Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.50
MAOA P21397 2/20 0.48
ALDH1A1 P00352 1/20 0.45
SCN9A Q15858 2/20 0.43
PTGES2 Q9H7Z7 1/20 0.43
CYP3A4 P08684 1/20 0.42
CASP1 P29466 1/20 0.42
RECQL P46063 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPK1 P28482 1/20 0.42
ADRA1A P35348 1/20 0.42
SCN4A P35499 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
PDE3A Q14432 1/20 0.42
SCN5A Q14524 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN3A Q9NY46 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.42
PLA2G7 Q13093 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3363485 0.86 CYP2A6 (0.58) MAP4K4MAOAALDH1A1SCN9ACYP3A4
SCHEMBL31607702 0.82 MAOA (0.47) MAP4K4MAOAALDH1A1CYP3A4CASP1
SCHEMBL31607686 0.81 MAOA (0.45) MAP4K4MAOAALDH1A1CYP3A4CASP1
SCHEMBL31607651 0.81 MAOA (0.45) MAP4K4MAOAALDH1A1CYP3A4CASP1
SCHEMBL31607595 0.81 MAOA (0.45) MAP4K4MAOAALDH1A1CYP3A4CASP1
SCHEMBL31607685 0.81 MAOA (0.45) MAP4K4MAOAALDH1A1CYP3A4CASP1
SCHEMBL2994341 0.79 CNR2 (0.50) MAOAALDH1A1SCN9ACYP3A4CYP2D6
SCHEMBL4445051 0.79 TDO2 (0.44) SCN9APTGES2NUDT1MEN1CYP2A6
SCHEMBL31607665 0.78 MAOA (0.47) MAP4K4MAOAALDH1A1CYP3A4CASP1
SCHEMBL28391909 0.78 MAOA (0.47) MAP4K4MAOAALDH1A1CYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed